{"disease":{"id":"b-cell-lymphoma-originating-in-the-cns","name":"b cell lymphoma originating in the cns"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01235793","title":"The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}